Inventaire - your friends and communities are your best library

Adaptive designs in clinical trials: why use them, and how to run and report them.

author

Philip Pallmann

Munyaradzi Dimairo

Laura Flight

James Wason

Christina Yap

published in: BMC Medicine

date of publication: 2018-02-28

language: English

Cites articles 105

Date

Title

Authors

2017-07-20

Implementing the EffTox dose-finding design in the Matchpoint trial

Kristian Brock, Lucinda J. Billingham, Christina Yap
2017-06-13

Estimation in multi-arm two-stage trials with treatment selection and time-to-event endpoint

Matthias Brueckner, Andrew C. Titman
2017-05-01

Recommendations for data monitoring committees from the Clinical Trials Transformation Initiative

Michael J Pencina
2017-04-24

The role of adaptive trial designs in drug development
2017-10-01

Bayesian clinical trial designs: Another option for trauma trials?

Philip Pallmann
2017-07-21

Dose Transition Pathways: The Missing Link Between Complex Dose-Finding Designs and Simple Decision-Making

Christina Yap, Lucinda J. Billingham, Charles Craddock
2016-11-01

An observational study of Donor Ex Vivo Lung Perfusion in UK lung transplantation: DEVELOP-UK.

Chrysovalanto Mamasoula, Kay D. Mann, Catherine Exley, Elaine McColl, Mark S Pearce
2016-11-27

Developing a Bayesian adaptive design for a phase I clinical trial: a case study for a novel HIV treatment

Deborah Ashby, Alexina J Mason, Alan Winston
2016-10-12

Response-adaptive clinical trials: case studies in the medical literature

Andy Grieve
2016-10-01

Data Monitoring Committees - Expect the Unexpected

Susan S Ellenberg
2016-07-29

Attitudes and opinions regarding confirmatory adaptive clinical trials: a mixed methods analysis from the Adaptive Designs Accelerating Promising Trials into Treatments (ADAPT-IT) project

William J Meurer, Timothy C. Guetterman
2016-07-01

What are the roles and valued attributes of a Trial Steering Committee? Ethnographic study of eight clinical trials facing challenges

Lucy Selman, Gillian W Shorter, Carrol Gamble, Rhiannon C Macefield, Anne Daykin, Sharon McCann
2016-07-02

Type I error rates of multi-arm multi-stage clinical trials: strong control and impact of intermediate outcomes

Daniel J Bratton, Patrick Phillips
2016-03-19

Adaptive designs undertaken in clinical research: a review of registered clinical trials

Laura Flight, Munyaradzi Dimairo
2016-02-29

Implementation of adaptive methods in early-phase clinical trials

Nolan A Wages
2016-02-24

Biomarker-Guided Adaptive Trial Designs in Phase II and Phase III: A Methodological Review

Miranta Antoniou
2016-06-01

Rendering the 3 + 3 Design to Rest: More Efficient Approaches to Oncology Dose-Finding Trials in the Era of Targeted Therapy
2015-12-30

Exploring the role and function of trial steering committees: results of an expert panel meeting

Douglas G. Altman, Matthew R Sydes, Nicola L. Harman, Carrol Gamble, Diana Elbourne, Elizabeth Conroy, Steff C Lewis, Marion K Campbell, Stephen Jw Evans, Judith M Bliss, Gordon Murray, John Norrie, Peter Sandercock
2015-12-23

Cross-sector surveys assessing perceptions of key stakeholders towards barriers, concerns and facilitators to the appropriate use of adaptive designs in confirmatory trials

Munyaradzi Dimairo
2015-12-23

Maximum type I error rate inflation from sample size reassessment when investigators are blind to treatment labels

Martin Posch
2015-11-03

An Investigation of the Shortcomings of the CONSORT 2010 Statement for the Reporting of Group Sequential Randomised Controlled Trials: A Methodological Systematic Review

Abigail Stevely, Munyaradzi Dimairo, Daniel Hind
2015-10-15

Telmisartan and Insulin Resistance in HIV (TAILoR): protocol for a dose-ranging phase II randomised open-labelled trial of telmisartan as a strategy for the reduction of insulin resistance in HIV-positive individuals on combination antiretroviral therapy

Sudeep P Pushpakom, Graham J Kemp, Saye Khoo, Munir Pirmohamed
2015-10-01

Patient-centric trials for therapeutic development in precision oncology

Andrew Biankin, Steven T. Piantadosi
2015-09-28

Missing steps in a staircase: a qualitative study of the perspectives of key stakeholders on the use of adaptive designs in confirmatory trials

Munyaradzi Dimairo
2015-09

An overview of the design and conduct of the BATTLE trials
2015-07-22

Prospective study evaluating the relative sensitivity of 18F-NaF PET/CT for detecting skeletal metastases from renal cell carcinoma in comparison to multidetector CT and 99mTc-MDP bone scintigraphy, using an adaptive trial design

James Wason, Haixi Yan, David J Lomas, Dmitry Soloviev, Ferdia A Gallagher
2015-07-14

Adaptive sample size modification in clinical trials: start small then ask for more?

Christopher Jennison
2015-06-17

Trial Steering Committees in randomised controlled trials: A survey of registered clinical trials units to establish current practice and experiences

Matthew R Sydes, Carrol Gamble
2015-07-01

No solution yet for combining two independent studies in the presence of heterogeneity
2015-04-22

Estimation after subpopulation selection in adaptive seamless trials

Peter K. Kimani, Nigel Stallard
2015-03-16

Twenty-five years of confirmatory adaptive designs: opportunities and pitfalls

Frank Bretz, Franz König
2015-01-14

Low-dose dexamethasone as a treatment for women with heavy menstrual bleeding: protocol for response-adaptive randomised placebo-controlled dose-finding parallel group trial (DexFEM)

Christopher J. Weir, Philippa Saunders

Article - wd:Q52681001

Welcome to Inventaire

the library of your friends and communities

learn more